TE
WST icon

Tema ETFs’s West Pharmaceutical WST Stock Holding History

Tema ETFs’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28M Buy
3,563
+290
+9% +$88.7K 0.04% 246
2026
Q1 		$820K Buy
3,273
+14
+0.4% +$3.48K 0.06% 269
2025
Q4 		$897K Sell
3,259
-8
-0.2% -$2.19K 0.07% 257
2025
Q3 		$857K Buy
3,267
+1,290
+65% +$314K 0.07% 287
2025
Q2 		$433K Sell
1,977
-292
-13% -$62.4K 0.11% 144
2025
Q1 		$508K Sell
2,269
-911
-29% -$251K 0.15% 110
2024
Q4 		$1.04M Buy
+3,180
New +$1M 0.43% 65

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Tema ETFs's WST Position: Q2 2026 in Review

Tema ETFs increased its West Pharmaceutical (WST) stake by 8.9% in Q2 2026, buying an estimated $88.7K and bringing the position to 3,563 shares worth $1.28M. The position accounts for 0.04% of the portfolio, ranked #246.

Tema ETFs first reported a position in WST in Q4 2024 and has held it in 7 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Tema ETFs held 3,563 shares of West Pharmaceutical worth $1.28M as of Q2 2026.
  • Tema ETFs bought 290 West Pharmaceutical shares in Q2 2026, an estimated $88.7K.
  • West Pharmaceutical made up 0.04% of Tema ETFs's portfolio in Q2 2026, its #246 holding.
  • Tema ETFs first reported a position in West Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.